Society guideline links: von Willebrand disease

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately:

●(See "Society guideline links: Immune thrombocytopenia (ITP) and other platelet disorders".)

●(See "Society guideline links: Hemophilia A and B".)

●(See "Society guideline links: Rare inherited bleeding disorders".)

●(See "Society guideline links: Acquired bleeding disorders".)

International

●American Society of Hematology (ASH), International Society on Thrombosis and Haemostasis (ISTH), National Hemophilia Foundation (NHF), and World Federation of Hemophilia (WFH): Guidelines on the diagnosis of von Willebrand disease (2021)

●ASH, ISTH, NHF, and WFH: Guidelines on the management of von Willebrand disease (2021)

Canada

●Canadian Hemophilia Society (CHS): Guidelines for the diagnosis of von Willebrand disease (VWD) (2012, revised 2018)

United States

●American Society of Hematology (ASH), International Society on Thrombosis and Haemostasis (ISTH), National Hemophilia Foundation (NHF), and World Federation of Hemophilia (WFH): Guidelines on the diagnosis of von Willebrand disease (2021)

●ASH, ISTH, NHF, and WFH: Guidelines on the management of von Willebrand disease (2021)

●NHF: Guidelines for pregnancy and perinatal management of women with inherited bleeding disorders and carriers of hemophilia A or B (2021)

●NHF: Medical and Scientific Advisory Council (MASAC) recommendations regarding diagnosis and management of inherited bleeding disorders in girls and women with personal and family history of bleeding (2021)

●NHF: MASAC recommendations regarding the treatment of von Willebrand disease (2021)

●NHF: Management of chronic pain in persons with bleeding disorders – Guidance for practical application of the Centers for Disease Control's opioid prescribing guidelines (2020)

●NHF: MASAC recommendations concerning products licensed for the treatment of hemophilia and other bleeding disorders (2020)

●American College of Obstetricians and Gynecologists (ACOG): Committee opinion on von Willebrand disease in women (2013, reaffirmed 2019)

●NHF: MASAC recommendations regarding physical therapy guidelines in patients with bleeding disorders (2015)

●NHF: MASAC recommendation regarding home factor supply for emergency preparedness for patients with hemophilia and other bleeding disorders (2014)

●NHF: MASAC recommendation regarding the use of recombinant clotting factor products with respect to pathogen transmission (2014)

●NHF: MASAC recommendations on administration of vaccines to individuals with bleeding disorders (2013)

●NHF: MASAC recommendations regarding standards of service for pharmacy provides of clotting factor concentrates for home use to patients with bleeding disorders (2008)

●National Heart, Lung, and Blood Institution (NHLBI): The diagnosis, evaluation, and management of von Willebrand disease (2007)

●NHF: MASAC recommendation regarding factor concentrate prescriptions and formulary development and restrictions (2005)

●NHF: MASAC recommendations on use of COX-2 inhibitors in persons with bleeding disorders (2005)

●NHF: Transition guidelines for people with bleeding disorders (2003)

United Kingdom

●United Kingdom Haemophilia Centres Doctors' Organisation (UKHCDO) and Royal College of Obstetricians & Gynaecologists (RCOG): Green-top guideline on the management of inherited bleeding disorders in pregnancy (2017)

●UKHCDO: Guidance on the dental management of patients with haemophilia and congenital bleeding disorders (2013, reviewed 2016)

●UKHCDO: Guideline for the diagnosis and management of von Willebrand disease (2014)

●UKHCDO: Emergency and out of hours care of patients with bleeding disorders – Standards of care for assessment and treatment (2009, reviewed 2013)

●UKHCDO: Guidance on vaccination against hepatitis A and B viruses in patients with inherited coagulation factor deficiencies and von Willebrand disease, update (2013)

●UKHCDO: Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders (2008, reviewed 2013)

●UKHCDO: Guideline on the molecular analysis of von Willebrand disease (2008)

●UKHCDO: Review with guidelines for the obstetric and gynaecological management of women with inherited bleeding disorders (2006)

Australia–New Zealand

●Australia Haemophilia Centre Directors' Organisation (AHCDO): Updated Australian consensus statement on management of inherited bleeding disorders in pregnancy (2019)

●AHCDO: A consensus statement on the dental treatment of patients with inherited bleeding disorders (2010)

●Australian Health Ministers' Advisory Council (AHMAC): Evidence-based clinical practice guidelines for the use of recombinant and plasma-derived FVIII and FIX products (2006)